Naomi Lämmlin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Naomi Lämmlin has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Dityatev
Molecular Neuroplasticity Group, German Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany
1 shared publication Anja Oelschlegel
Leibniz‐Institute for Neurobiology
1 shared publicationAxel Becker
Otto‐von‐Guericke University
1 shared publication- Daniel Gündel
Department of Neuroradiopharmaceuticals, Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Leipzig, Germany
1 shared publication - Grazyna Debska‐Vielhaber
Department of Neurology Otto‐von‐Guericke University Magdeburg Germany
1 shared publication Hasanuzzaman
Otto‐von‐Guericke University
1 shared publication
Latest Publications
- Open Access
- 17 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (6) , e040710
Vascular and Neural Transcriptomics Reveal Stage‐Dependent Pathways to Inflammation and Cognitive Dysfunction in a Rat Model of Hypertension
Background: Chronic arterial hypertension causes cerebral microvascular dysfunction and increases dementia risk in aging. However, cognitive health preservation by therapeutic blood pressure lowering alone is limited and depends on disease duration, the degree of irreversible tissue damage, and whether microvascular function can be restored. This study aimed to understand molecular and cellular temporospatial mechanisms of disease in the course of hypertension. Methods: We investigated the effects of initial, early chronic and late chronic hypertension in the frontal brain of spontaneously hypertensive stroke‐prone rats by applying behavioral tests, histopathology, immunofluorescence, fluorescence‐activated cell sorting, microvascular/neural tissue RNA sequencing, and 18 F‐fluorodeoxyglucose positron emission tomography imaging. Results: Chronic hypertension caused behavioral deficits associated with frontal cortex function. Our results highlight stage‐dependent responses to continuous microvascular stress and wounding by hypertension. Early chronic responses included a fast recruitment of activated microglia to the blood vessels, immigration of peripheral immune cells, blood–brain barrier breakdown and an energy‐demanding hypermetabolic state. Vascular adaptation mechanisms were observed in later stages and included angiogenesis and upregulation of cellular adhesion molecules and extracellular matrix. Among the top upregulated genes in blood vessels, we identified Igfbp‐5 , which attenuates protective insulin‐like growth factor 1 signaling. Conclusions: Our study provides new insight into mechanisms underlying hypertensive pathobiology and highlights its stage‐dependent nature. This groundwork will be helpful for basic and clinical research to identify stage‐dependent markers in the human disease course, investigate stage‐dependent interventions besides blood pressure lowering, and better understand the relationship between poor vascular health and neurodegenerative diseases.
- 17 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (6) , e040710
Open AccessVascular and Neural Transcriptomics Reveal Stage‐Dependent Pathways to Inflammation and Cognitive Dysfunction in a Rat Model of Hypertension
Background: Chronic arterial hypertension causes cerebral microvascular dysfunction and increases dementia risk in aging. However, cognitive health preservation by therapeutic blood pressure lowering alone is limited and depends on disease duration, the degree of irreversible tissue damage, and whether microvascular function can be restored. This study aimed to understand molecular and cellular temporospatial mechanisms of disease in the course of hypertension. Methods: We investigated the effects of initial, early chronic and late chronic hypertension in the frontal brain of spontaneously hypertensive stroke‐prone rats by applying behavioral tests, histopathology, immunofluorescence, fluorescence‐activated cell sorting, microvascular/neural tissue RNA sequencing, and 18 F‐fluorodeoxyglucose positron emission tomography imaging. Results: Chronic hypertension caused behavioral deficits associated with frontal cortex function. Our results highlight stage‐dependent responses to continuous microvascular stress and wounding by hypertension. Early chronic responses included a fast recruitment of activated microglia to the blood vessels, immigration of peripheral immune cells, blood–brain barrier breakdown and an energy‐demanding hypermetabolic state. Vascular adaptation mechanisms were observed in later stages and included angiogenesis and upregulation of cellular adhesion molecules and extracellular matrix. Among the top upregulated genes in blood vessels, we identified Igfbp‐5 , which attenuates protective insulin‐like growth factor 1 signaling. Conclusions: Our study provides new insight into mechanisms underlying hypertensive pathobiology and highlights its stage‐dependent nature. This groundwork will be helpful for basic and clinical research to identify stage‐dependent markers in the human disease course, investigate stage‐dependent interventions besides blood pressure lowering, and better understand the relationship between poor vascular health and neurodegenerative diseases.